28
Sun, May
4 New Articles

Immuneering Corporation announced today that it has entered into an agreement to expand its existing relationship with Bristol-Myers Squibb for the use of Immuneering’s proprietary computational biology methods to identify biological insights that may facilitate discovery and development of medicines. Terms of agreement were not disclosed.

In the largest and longest head-to-head comparison of two anti-clotting medications, warfarin and aspirin were similar in preventing deaths and strokes in heart failure patients with normal heart rhythm, according to late-breaking research presented at the American Stroke Association's International Stroke Conference 2012.

More Articles ...

Sign up via our free email subscription service to receive notifications when new information is available.
captcha